10-QPeriod: Q1 FY1999

MCKESSON CORP Quarterly Report for Q1 Ended Jun 30, 1998

Filed August 10, 1998For Securities:MCK

Summary

McKesson Corporation's 10-Q filing for the period ending June 29, 1998, indicates a company in a growth phase with a focus on its core pharmaceutical distribution business. While specific financial figures are not detailed in the provided text, the filing likely details operational performance and strategic initiatives aimed at expanding market share and enhancing service offerings within the healthcare supply chain. Investors should note McKesson's position as a key player in the distribution of pharmaceuticals and medical supplies. The company's performance is intrinsically linked to the healthcare industry's dynamics, including prescription drug trends, healthcare reform, and managed care penetration. This report serves as an important update on the company's progress during the quarter, highlighting its ongoing efforts to navigate a competitive landscape and deliver value to its stakeholders.

Key Highlights

  • 1McKesson Corporation is reporting its quarterly financial performance for the period ending June 29, 1998.
  • 2The filing is a 10-Q, indicating it's a quarterly report detailing the company's operational and financial standing.
  • 3McKesson operates within the pharmaceutical distribution and healthcare services sector.
  • 4The company's performance is influenced by broader trends in the healthcare industry, including drug utilization and managed care.
  • 5This report provides an update on McKesson's business activities and financial health during the specified quarter.
  • 6Investors can use this filing to assess the company's recent performance and its strategic direction.

Frequently Asked Questions

McKesson Corporation is primarily involved in the distribution of pharmaceuticals and medical-legal services, operating as a key intermediary in the healthcare supply chain.

A 10-Q filing contains unaudited financial statements (balance sheets, income statements, cash flow statements), management's discussion and analysis of financial condition and results of operations, and other relevant disclosures for the quarterly period.

Key factors influencing McKesson's performance include prescription drug trends, healthcare reform initiatives, the growth of managed care organizations, competition within the pharmaceutical distribution market, and operational efficiency.

No, the financial statements included in a 10-Q filing are typically unaudited. Audited financial information is usually provided in the company's annual report (10-K filing).